{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T21:00:40Z","timestamp":1780174840810,"version":"3.54.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jbiotec.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:33:31Z","timestamp":1778567611000},"page":"175-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Increased mRNA-lipid nanoparticle transfection per ng mRNA by concentrating cells"],"prefix":"10.1016","volume":"416","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1686-3603","authenticated-orcid":false,"given":"Alina","family":"Kunitskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-0449","authenticated-orcid":false,"given":"Sunny P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-2680","authenticated-orcid":false,"given":"Chia Hao","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melaina","family":"Del Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5812-9689","authenticated-orcid":false,"given":"Anna K.","family":"Blakney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Piret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jbiotec.2026.05.003_bib1","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/S2352-3026(21)00060-0","article-title":"Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study","volume":"8","author":"Azoulay","year":"2021","journal-title":"Lancet Haematol."},{"issue":"2\u20133","key":"10.1016\/j.jbiotec.2026.05.003_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0166-0934(95)00035-S","article-title":"Centrifugal enhancement of retroviral mediated gene transfer","volume":"54","author":"Bahnsonz","year":"1995","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib3","article-title":"Non-viral chimeric antigen receptor (CAR) T cells going viral","volume":"18","author":"Balke-Want","year":"2023","journal-title":"Immuno-Oncol. Technol."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib4","article-title":"A distinct subset of highly proliferative and lentiviral vector (lv)-transducible NK cells define a readily engineered subset for adoptive cellular therapy","volume":"10","author":"Bari","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114047","article-title":"The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity","volume":"386","author":"Bates","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.28","article-title":"Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA","volume":"1","author":"Belliveau","year":"2012","journal-title":"Mol. Ther. - Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acs.nanolett.1c02503","article-title":"Orthogonal design of experiments for optimization of lipid nanoparticles for mRNA engineering of CAR T cells","volume":"22","author":"Billingsley","year":"2022","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.003_bib8","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib9","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jconrel.2020.11.033","article-title":"Effect of complexing lipids on cellular uptake and expression of messenger RNA in human skin explants","volume":"330","author":"Blakney","year":"2021","journal-title":"J. Control. Release"},{"issue":"1\u20133","key":"10.1016\/j.jbiotec.2026.05.003_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1021174619613","article-title":"Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale","volume":"38","author":"Bohnenkamp","year":"2002","journal-title":"Cytotechnology"},{"issue":"13","key":"10.1016\/j.jbiotec.2026.05.003_bib11","first-page":"S253","article-title":"Improving outcomes and mitigating costs associated with CAR T-cell therapy","volume":"27","author":"Borgert","year":"2021","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib12","article-title":"Reliable particle sizing in vaccine formulations using advanced dynamic light scattering","author":"Bretz","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2023.101705","article-title":"Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery","volume":"66","author":"C\u00e1rdenas","year":"2023","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00482","article-title":"Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: experience from an academic phase I clinical trial","volume":"11","author":"Castella","year":"2020","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.jbiotec.2026.05.003_bib15","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1002\/1873-3468.13268","article-title":"Time course and temperature dependence of synaptic vesicle endocytosis","volume":"592","author":"Chanaday","year":"2018","journal-title":"FEBS Lett."},{"issue":"31","key":"10.1016\/j.jbiotec.2026.05.003_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303370","article-title":"Induction of Bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib17","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11165","article-title":"Transfection types, methods and strategies: a technical review","volume":"9","author":"Chong","year":"2021","journal-title":"PeerJ"},{"issue":"13","key":"10.1016\/j.jbiotec.2026.05.003_bib18","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1089\/hum.1996.7.13-1527","article-title":"Retroviral infection is limited by Brownian motion","volume":"7","author":"Chuck","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2020.107868","article-title":"Lentiviral vector bioprocess economics for cell and gene therapy commercialization","volume":"167","author":"Comisel","year":"2021","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.omtm.2022.11.009","article-title":"Meeting FDA guidance recommendations for replication-competent virus and insertional oncogenesis testing","volume":"28","author":"Cornetta","year":"2023","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib21","first-page":"1","article-title":"Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments","volume":"21","author":"Dagar","year":"2023","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.jbiotec.2026.05.003_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"September","key":"10.1016\/j.jbiotec.2026.05.003_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.omtm.2018.08.002","article-title":"A nontoxic transduction enhancer enables highly efficient lentiviral transduction of primary murine T cells and hematopoietic stem cells","volume":"10","author":"Delville","year":"2018","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"issue":"R1","key":"10.1016\/j.jbiotec.2026.05.003_bib24","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","article-title":"Progress and challenges in viral vector manufacturing","volume":"25","author":"van der Loo","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01559-z","article-title":"Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing","volume":"21","author":"Dimitri","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1536867X1501500117","article-title":"Nonparametric pairwise multiple comparisons in independent groups using Dunn\u2019s Test","volume":"15","author":"Dinno","year":"2015","journal-title":"Stata J. Promot. Commun. Stat. Stata"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2023.08.014","article-title":"Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells","volume":"361","author":"Douka","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib28","article-title":"Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicine","author":"Elverum","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115065","article-title":"vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy","volume":"165","author":"Escalona-Rayo","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.17","article-title":"Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells","volume":"2","author":"Fenard","year":"2013","journal-title":"Mol. Ther. - Nucleic Acids"},{"issue":"2","key":"10.1016\/j.jbiotec.2026.05.003_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/17425247.2012.642363","article-title":"Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics","volume":"9","author":"Gindy","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.jbiotec.2026.05.003_bib32","first-page":"324","article-title":"Cancer immunotherapy with CAR-T cells - behold the future","volume":"18","author":"Graham","year":"2018","journal-title":"Clin. Med. J. R. Coll. Physicians"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301515","article-title":"Ionizable lipid nanoparticles with integrated immune checkpoint inhibition for mRNA CAR T cell engineering","author":"Hamilton","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.jbiotec.2026.05.003_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"6","key":"10.1016\/j.jbiotec.2026.05.003_bib36","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1007\/s12325-022-02087-4","article-title":"Real-WOrld Treatment Patterns After CD19-directed CAR T cell therapy among patients with diffuse large B cell lymphoma","volume":"39","author":"Jalbert","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.003_bib38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm.4478","article-title":"A novel chimeric antigen receptor containing a JAK\u2013STAT signaling domain mediates superior antitumor effects","volume":"24","author":"Kagoya","year":"2018","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.jbiotec.2026.05.003_bib39","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.3390\/pharmaceutics14112357","article-title":"Stability study of mRNA-lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability","volume":"14","author":"Kamiya","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib40","article-title":"CRISPR\/Cas9 encouraged CAR-T cell immunotherapy reporting efficient and safe clinical results towards cancer","volume":"33","author":"Khan","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101139","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib42","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1038\/s41467-021-26719-5","article-title":"Tracking Brownian motion in three dimensions and characterization of individual nanoparticles using a fiber-based high-finesse microcavity","volume":"12","author":"Kohler","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jbiotec.2026.05.003_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jcyt.2025.01.002","article-title":"Impacts of transient exposure of human T cells to low oxygen, temperature, pH and nutrient levels relevant to bioprocessing for cell therapy applications","volume":"27","author":"Kunitskaya","year":"2025","journal-title":"Cytotherapy"},{"issue":"26","key":"10.1016\/j.jbiotec.2026.05.003_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211420","article-title":"Optimizing lipid nanoparticles for delivery in primates","volume":"35","author":"Lam","year":"2023","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.jbiotec.2026.05.003_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2022-005189","article-title":"Automated, scaled, transposon-based production of CAR T cells","volume":"10","author":"Lock","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.jbiotec.2026.05.003_bib46","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acs.molpharmaceut.2c00032","article-title":"Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach","volume":"19","author":"Ly","year":"2022","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.jbiotec.2026.05.003_bib47","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1074\/jbc.M115.675033","article-title":"Molecular determinants of vectofusin-1 and its derivatives for the enhancement of lentivirally mediated gene transfer into hematopoietic stem\/progenitor cells","volume":"291","author":"Majdoul","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymthe.2017.10.012","article-title":"Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients","volume":"26","author":"Marcucci","year":"2018","journal-title":"Mol. Ther."},{"issue":"7897","key":"10.1016\/j.jbiotec.2026.05.003_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","article-title":"Descriptive statistics and normality tests for statistical data","volume":"22","author":"Mishra","year":"2019","journal-title":"Ann. Card. Anaesth."},{"issue":"23","key":"10.1016\/j.jbiotec.2026.05.003_bib51","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V126.23.2043.2043","article-title":"Automated lentiviral transduction of T cells with cars using the clinimacs prodigy","volume":"126","author":"Mock*","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib52","series-title":"Translational Biology in Medicine","first-page":"9","article-title":"Model systems","author":"Montano","year":"2014"},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50981-9","article-title":"A microfluidic device to enhance viral transduction efficiency during manufacture of engineered cellular therapies","volume":"9","author":"Moore","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.867013","article-title":"The past, present, and future of non-viral CAR T cells","volume":"13","author":"Moretti","year":"2022","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.jbiotec.2026.05.003_bib55","article-title":"A combinatorial library of lipid nanoparticles for cell type-specific mRNA delivery","volume":"10","author":"Naidu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119652","article-title":"Lipid nanoparticles fuse with cell membranes of immune cells at low temperatures leading to the loss of transfection activity","volume":"587","author":"Nakamura","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib57","unstructured":"National Cancer Institute, \u201cCAR T Cells: Engineering Patients\u2019 Immune Cells to Treat Their Cancers,\u201d 2022. \u3008https:\/\/www.cancer.gov\/about-cancer\/treatment\/research\/car-t-cells\u3009."},{"issue":"22","key":"10.1016\/j.jbiotec.2026.05.003_bib58","doi-asserted-by":"crossref","first-page":"18102","DOI":"10.1039\/C5RA25333K","article-title":"Nanoparticles as transfection agents: a comprehensive study with ten different cell lines","volume":"6","author":"Neuhaus","year":"2016","journal-title":"RSC Adv."},{"issue":"21","key":"10.1016\/j.jbiotec.2026.05.003_bib59","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding","volume":"74","author":"O\u2019Doherty","year":"2000","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.jbiotec.2026.05.003_bib60","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/pharmaceutics14091940","article-title":"Microfluidic manufacture of lipid-based nanomedicines","volume":"14","author":"Osouli-Bostanabad","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jbiotec.2026.05.003_bib61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4028\/www.scientific.net\/AMM.611.115","article-title":"Methodology and application of the Kruskal-Wallis test","volume":"611","author":"Ostertagov\u00e1","year":"2014","journal-title":"Appl. Mech. Mater."},{"issue":"9","key":"10.1016\/j.jbiotec.2026.05.003_bib62","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41434-021-00254-w","article-title":"CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma","volume":"28","author":"Prommersberger","year":"2021","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.93","article-title":"Antibody-based CAR T cells produced by lentiviral transduction","volume":"128","author":"Prommersberger","year":"2020","journal-title":"Curr. Protoc. Immunol."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12860-021-00397-z","article-title":"Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells","volume":"22","author":"Rajabzadeh","year":"2021","journal-title":"BMC Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.jbiotec.2026.05.003_bib65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/intbio\/zyz030","article-title":"Correlation of mRNA delivery timing and protein expression in lipid-based transfection","volume":"11","author":"Reiser","year":"2019","journal-title":"Integr. Biol."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib66","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13287-021-02406-6","article-title":"Nonviral genome engineering of natural killer cells","volume":"12","author":"Robbins","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2022.11.036","article-title":"siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles","volume":"353","author":"Sakurai","year":"2023","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jbiotec.2026.05.003_bib68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","article-title":"Risks associated with lentiviral vector exposures and prevention strategies","volume":"58","author":"Schlimgen","year":"2016","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.611163","article-title":"Engineering NK Cells for CAR therapy\u2014recent advances in gene transfer methodology","volume":"11","author":"Schmidt","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jbiotec.2026.05.003_bib70","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun. Signal"},{"issue":"44","key":"10.1016\/j.jbiotec.2026.05.003_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning lipid nanoparticles for RNA delivery to extrahepatic organs","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.jbiotec.2026.05.003_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib74","doi-asserted-by":"crossref","first-page":"18071","DOI":"10.1038\/s41598-022-23013-2","article-title":"Development of lipid nanoparticles and liposomes reference materials (II): cytotoxic profiles","volume":"12","author":"Syama","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbiotec.2026.05.003_bib75","unstructured":"Thomas, A., Brown, A., Souza, R.De, Fernandez, T., 2022. \u201cNonviral modification of T cell gene expression,\u201d US 2022\/0162552 A1."},{"issue":"13","key":"10.1016\/j.jbiotec.2026.05.003_bib76","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319856121","article-title":"IL7 increases targeted lipid nanoparticle\u2013mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation","volume":"121","author":"Tilsed","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.jbiotec.2026.05.003_bib77","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.ymthe.2017.07.002","article-title":"Microfluidic transduction harnesses mass transport principles to enhance gene transfer efficiency","volume":"25","author":"Tran","year":"2017","journal-title":"Mol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.jbiotec.2026.05.003_bib78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-1759(02)00431-3","article-title":"Rapid and highly efficient gene transfer into natural killer cells by nucleofection","volume":"274","author":"Trompeter","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.jbiotec.2026.05.003_bib79","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jcyt.2013.06.003","article-title":"Simplified process for the production of anti\u2013CD19-CAR\u2013engineered T cells","volume":"15","author":"Tumaini","year":"2013","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jbiotec.2026.05.003_bib80","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/S0021-9258(19)69656-0","article-title":"Temperature dependence of endocytosis mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. Evidence for two potentially rate-limiting steps","volume":"256","author":"Weigel","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jbiotec.2026.05.003_bib81","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acsbiomaterials.1c01532","article-title":"Vitro engineering chimeric antigen receptor macrophages and T cells by lipid nanoparticle-mediated mRNA delivery","volume":"8","author":"Ye","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib82","doi-asserted-by":"crossref","first-page":"21868","DOI":"10.1038\/s41598-023-49027-y","article-title":"Caspase inhibition improves viability and efficiency of liposomal transfection","volume":"13","author":"Yoshida","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jbiotec.2026.05.003_bib83","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41408-022-00688-4","article-title":"Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia","volume":"12","author":"Zhang","year":"2022","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40364-022-00364-6","article-title":"CAR-NK cells for cancer immunotherapy: from bench to bedside","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.003_bib85","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12896-018-0419-0","article-title":"Optimized DNA electroporation for primary human T cell engineering","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Biotechnol."}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165626001562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165626001562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:19:22Z","timestamp":1780172362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165626001562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":85,"alternative-id":["S0168165626001562"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2026.05.003","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased mRNA-lipid nanoparticle transfection per ng mRNA by concentrating cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}